Ariane’s Mark Davies will be giving a talk on what the patient wants on Wednesday 7th June 2023
For more details please visit https://www.rsm.ac.uk/events/oncology/2022-23/ocr01/
Company News
2019 Biotechnology Awards – WINNER
GHP Announces the 2019 Biotechnology Awards Winners
GHP Magazine has announced the winners of the 2019 Biotechnology Awards.
Most Innovative Cancer Treatment Manufacturer – Midlands
Ariane Medical Systems Ltd was delighted to be announced winners of the Most Innovative Cancer Treatment Manufacturer – Midlands regional category. Following on from our Medilink Innovation Award in June 2018 this award further shows how Papillon Brachytherapy Systems have brought new life to an old cancer treatment technique.
Ariane Macmillan Coffee Morning
Ariane Macmillan Coffee Morning – 28th September 2018 10am to 12 noon.
Join Ariane Medical Systems as we host our Macmillan Coffee Morning on 28th September 2018.
Our coffee morning will take place between 10 am and 12 noon at Ariane Medical Systems Ltd, 151 Mansfield Road, Alfreton, DE55 7JQ.
Clatterbridge Cancer Centre win BMJ Award for Rectal Cancer Care
Clatterbridge Cancer Center win Prestigious UK Cancer Care Award
Introduction
A coveted British Medical Journal award was recently bestowed on the Papillon team at The Clatterbridge Cancer Center. The Cancer Care Team category was won by the entry—Papillon for Rectal Cancer.
This life-changing treatment was pioneered by The Clatterbridge Cancer Center when Lead Papillon Clinician Professor Arthur Sun Myint initially introduced the method to the United Kingdom, more than two decades ago. He stated that the honour was the reward for the team’s hard work and their philosophy of always putting patients’ interest first.
Papillon Patients in Phase III Opera Trial
The Phase III trial called OPERA which started in France at the end of 2015 has now passed Ethics here in the UK.
Phase III Clinical Trial OPERA starts
The Organ Preservation of Early Rectal Adenocarcinoma (OPERA) phase III trial has started to recruit patients at the Centre Antoine-Lacassagne in Nice, France. This Pan-European trial, developed by Prof Jean-Pierre Gerard (Nice) and Prof Arthur Sun Myint (Clatterbridge, UK) is looking to recruit patients across existing Papillon users in France, UK, Sweden, Denmark and Switzerland as well as driving interest in new territories.
Arianes’ Papillon X-ray Brachy makes National Press with Nottingham City Hospital
Papillon X-ray Brachy is making national Press, after its NICE ratification, with its use of low energy X-rays to kill cancer cells; allowing better local control of small rectal cancer tumours and offering patients a real alternative to radical surgery and a permanent stoma.
The bowel cancer operation that means you DON’T need a colostomy bag
- Businesswoman Judith Blount was diagnosed with bowel cancer in 2014 after she noticed blood when she went to the loo
- Doctors told her she’d need her rectum removed and have to wear a colostomy bag for the rest of her life
- Instead, she tried a treatment using low-energy radiotherapy called Papillon, which successfully cured her
A new, less invasive form of radiotherapy is now recommended for bowel cancer by the health watchdog. Judith Blount, 49, a businesswoman from Derbyshire, underwent the treatment…
NICE ratify Papillon low energy X-ray Brachytherapy treatment for UK rectal cancer patients
The National Institute of Health & Care Excellence (NICE) have finished their consultation period for the use of Papillon X-Ray Brachytherapy for the treatment of rectal tumours and published their recommendations..